In discovering how certain chemotherapy drugs cause the nerve damage known as peripheral neuropathy, researchers at Dana-Farber Cancer Institute have found a potential approach to preventing this common and troublesome side effect of cancer...
10-Oct-2017 7:05 AM EDT Add to Favorites
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to...
6-Oct-2017 2:40 PM EDT Add to Favorites
Cell Cycle-Blocking Drugs Can Shrink Tumors by Enlisting Immune System in Attack on Cancer, Study Finds
• Study explains why CDK4/6 inhibitors can shrink tumor in some advanced breast cancers
• CDK4/6 inhibitors trigger the immune system to attack tumor cells
• CDK4/6 inhibitors can also enhance anti-cancer effect of immunotherapy agents
15-Aug-2017 1:00 PM EDT Add to Favorites
Dana-Farber /Brigham and Women's Cancer Center is ranked no. 4 in cancer by U.S. News and World Report.
8-Aug-2017 9:10 AM EDT Add to Favorites
The Dana-Farber Cancer Institute is pleased to announce the opening of the new Leonard P. Zakim Center for Integrative Therapies and Healthy Living, underscoring Dana-Farber’s commitment to providing cutting-edge patient therapies and support for...
7-Aug-2017 10:05 AM EDT Add to Favorites
Four Dana-Farber Researchers Awarded Prestigious “Outstanding Investigator Awards” by National Cancer Institute
The National Cancer Institute (NCI) has awarded four Dana-Farber Cancer Institute researchers with Outstanding Investigator Awards (OIA) for ongoing progressive research within their respective areas of study.
2-Jun-2017 10:05 AM EDT Add to Favorites
Dana-Farber Cancer Institute has named Lesley Solomon to the newly-created position of senior vice president for innovation and chief innovation officer. Solomon has been serving as executive director of the Brigham Innovation Hub at Brigham and...
31-May-2017 11:05 AM EDT Add to Favorites
A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.
5-May-2017 12:05 PM EDT Add to Favorites
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT